Provided by Tiger Trade Technology Pte. Ltd.

SBP GROUP

5.260
-0.120-2.23%
Volume:66.41M
Turnover:351.91M
Market Cap:98.27B
PE:34.74
High:5.460
Open:5.450
Low:5.240
Close:5.380
52wk High:8.901
52wk Low:4.136
Shares:18.68B
HK Float Shares:18.68B
Volume Ratio:0.70
T/O Rate:0.36%
Dividend:0.12
Dividend Rate:2.33%
EPS(LYR):0.151
ROE:14.07%
ROA:7.51%
PB:2.59
PE(LYR):34.74
PS:2.50

Loading ...

Stock Track | SBP GROUP Soars 5.63% Intraday on Buyback Plan, Pipeline Milestones, and Sector Rally

Stock Track
·
Jun 29

Movement Alert|Sino Biopharmaceutical Rises 3.05% in Regular Trading, Pharmaceuticals Sector Rallies Broadly Amid Buyback Support and Pipeline Momentum

Market Focus
·
Jun 29

SPB Group Allocates HK$49.1 Million for Share Buyback on June 25

Stock News
·
Jun 25

Sino Biopharmaceutical Files HKEX Next-day Disclosure Return on Share Repurchase for Cancellation

Reuters
·
Jun 25

Sino Biopharmaceutical Stock Sheds 3.4% in Hong Kong, Underperforms Competitors

Dow Jones
·
Jun 25

Movement Alert|Sino Biopharmaceutical Falls 3.17% in Regular Trading, Pharmaceutical Sector Retreats Again Amid Persistent High Short-Selling Ratio

Market Focus
·
Jun 25

Stock Track | SBP GROUP Soars 5.03% Intraday on Dual Pipeline Catalysts and Share Buyback Program

Stock Track
·
Jun 24

Movement Alert|Sino Biopharmaceutical Rises 3.2% in Regular Trading, Dual Pipeline Catalysts and Sector Recovery Drive Gains

Market Focus
·
Jun 24

Sino Biopharmaceutical Unit Gets Marketing Nod for Wound Treatment Drug in China

MT Newswires Live
·
Jun 23

Sino Biopharmaceutical Unit's Application for Gastric Cancer Drug Accepted in China

MT Newswires Live
·
Jun 23

Sino Biopharmaceutical Says China's CDE Accepts New Drug Application For Tecotabart Vedotin (LM-302)

Reuters
·
Jun 23

SBP GROUP’s Subsidiary Secures NMPA Marketing Approval for First-in-Class Peceleganan Spray

Bulletin Express
·
Jun 23

SPB Group's Novel Peilaijianan Spray Receives Market Authorization in China

Stock News
·
Jun 23

Innovative CLDN18.2 ADC Drug from SBP GROUP Subsidiary Sees Marketing Application Accepted in China

Stock News
·
Jun 23

Sino Biopharmaceutical - Peceleganan Spray Receives Marketing Approval From China's Nmpa

THOMSON REUTERS
·
Jun 23

Sino Biopharm says China regulator accepts LM-302 gastric cancer drug application for priority review

Reuters
·
Jun 23

Sino Biopharmaceutical - China's Cde Accepts New Drug Application for Tecotabart Vedotin (Lm-302)

THOMSON REUTERS
·
Jun 23

SBP GROUP's CEO Discusses Chinese Pharma's Growing Global Ambitions

Deep News
·
Jun 23

Movement Alert|Sino Biopharmaceutical Rises 3.15% in Regular Trading, Pharma Sector Rebounds Collectively as HK$2 Billion Buyback Plan Provides Support

Market Focus
·
Jun 23

Sino Biopharmaceutical Stock Slips 2.8% in Hong Kong, Underperforms Competitors

Dow Jones
·
Jun 22